The Department of Health and Human Services says it’s using DNA tests to help reunite 3,000 immigrant children separated from their parents—but won’t say who is doing the tests.
The situation: The agency is under an order from a US. federal district court to reunite alien minors under five years old with their parents. It says DNA tests are a fast way to do it.
The background: Immigrants frequently pay for DNA tests to establish that they’re related to someone in the US. However, genetic tests have never been used to untangle a mass round-up like this one.
Ethical problems: Testing a child’s DNA requires consent of a parent or guardian. Without knowing who the children’s parents are, it’s unclear how the US government can obtain that consent. “If a child can’t verbalize who their parent is, DNA is an excellent way to find out,” says Michael Baird, chief science officer of DNA Diagnostics Center, a testing company based in Ohio. “But I don’t know how a child under five, or even over five, can legally consent to a test.” Nevertheless, federal law states that unaccompanied kids in HHS’s custody are the agency’s responsibility, and it can place them in foster homes and make medical decisions for them. That could include taking their DNA.
How the tests work: Identification tests look at a dozen genetic markers calls short-tandem repeats, or STRs. They’re the same kind used in paternity disputes and by police. STRs don’t contain any health information. The government says the testing results on immigrants will be discarded later.
Results so far: According to HHS, some people claiming to be parents aren’t really—and a few have already admitted it when asked to take a DNA test. On July 10, the agency said 34 parents had already cleared a criminal check and taken a DNA test linking them to their kids.
The mystery: HHS has refused to say who is performing the tests. Although the DNA tests themselves are mostly infallible, the logistics of keeping track of everyone’s samples isn’t. A mix-up could lead to a wrong conclusion that a parent and child aren’t actually related.
These scientists used CRISPR to put an alligator gene into catfish
The resulting fish appear to be more resistant to disease and could improve commercial production—should they ever be approved.
Next up for CRISPR: Gene editing for the masses?
Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.
CRISPR for high cholesterol: 10 Breakthrough Technologies 2023
New forms of the gene-editing tool could enable treatments for common diseases.
An ALS patient set a record for communicating via a brain implant: 62 words per minute
Brain interfaces could let paralyzed people speak at almost normal speeds.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.